← Eichor
Condition: Polypoidal Choroidal Vasculopathy Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Polypoidal Choroidal Vasculopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Va
Phase 4 · 31 location(s) · Association for Innovation and Biomedical Research on Light · NCT06709339Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal
Phase 3 · 1 location(s) · Yeungnam University College of Medicine · NCT07461441Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive P
Phase 3 · 1 location(s) · Yeungnam University College of Medicine · NCT07389980OCT in Rare Chorioretinal Diseases
Phase N/A · 1 location(s) · Oregon Health and Science University · NCT02141308Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Wi
Phase 3 · 1 location(s) · SANGMYUNG innovation · NCT07695207
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.